Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -7.7120.295.8813.6121.24

What is the latest Core EBITDA Growth ratio of LINCOLN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of LINCOLN PHARMACEUTICALS is -7.71 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-7.71
Mar202420.29
Mar20235.88
Mar202213.61
Mar202121.24

How is Core EBITDA Growth of LINCOLN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -7.71
Negative
Mar2024 20.29
245.07
Mar2023 5.88
-56.80
Mar2022 13.61
-35.92
Mar2021 21.24 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,214.3 Cr -3.8% -17.2% 8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,148.0 Cr 2.6% 1.2% 13% Stock Analytics
DIVIS LABORATORIES ₹179,009.0 Cr 1.3% -2.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,779.0 Cr 1.5% 0.7% 37.1% Stock Analytics
CIPLA ₹115,772.0 Cr 6.1% 2.4% -5.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,616.0 Cr 2.6% -0.4% -2.1% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-3.8%

-17.2%

8%

SENSEX

-0.8%

1.4%

-6.8%


You may also like the below Video Courses